Huo TI - Search Results

1

Risk factors for long-term prognosis in hepatocellular carcinoma after radiofrequency ablation therapy: the clinical implication of aspartate aminotransferase-platelet ratio index.

Kao WY, Chiou YY, Hung HH, Chou YH, Su CW, Wu JC, Huo TI, Huang YH, Lin HC, Lee SD. Kao WY, et al. Among authors: huo ti. Eur J Gastroenterol Hepatol. 2011 Jun;23(6):528-36. doi: 10.1097/MEG.0b013e328346d529. Eur J Gastroenterol Hepatol. 2011. PMID: 21537128

2

Survival benefit of cirrhotic patients with hepatocellular carcinoma treated by percutaneous ethanol injection as a salvage therapy.

Huo TI, Huang YH, Wu JC, Lee PC, Chang FY, Lee SD. Huo TI, et al. Scand J Gastroenterol. 2002 Mar;37(3):350-5. doi: 10.1080/003655202317284273. Scand J Gastroenterol. 2002. PMID: 11916199

3

Comparison of clinical manifestations and epidemiology between acute hepatitis A and acute hepatitis E in Taiwan.

Su CW, Wu JC, Huang YS, Huo TI, Huang YH, Lin CC, Chang FY, Lee SD. Su CW, et al. Among authors: huo ti. J Gastroenterol Hepatol. 2002 Nov;17(11):1187-91. doi: 10.1046/j.1440-1746.2002.02858.x. J Gastroenterol Hepatol. 2002. PMID: 12453278

4

Characteristics of autoimmune hepatitis in Taiwan: the 11 years' experiences of a medical center.

Huang HC, Huang YS, Wu JC, Tsay SH, Huo TI, Wang YJ, Lo JC, Chen CY, Li CP, Chang FY, Lee SD. Huang HC, et al. Among authors: huo ti. Zhonghua Yi Xue Za Zhi (Taipei). 2002 Dec;65(12):563-9. Zhonghua Yi Xue Za Zhi (Taipei). 2002. PMID: 12636201

5

Screening for hepatocellular carcinoma in high-risk patients: Western versus Eastern virus.

Huo TI, Lee SD, Wu JC. Huo TI, et al. Hepatology. 2003 Jul;38(1):269; author reply 270. doi: 10.1053/jhep.2003.50236. Hepatology. 2003. PMID: 12830012 No abstract available.

6

Outcomes of patients with seroclearance of HBsAg: different facets of the truth.

Huo TI, Wu JC, Lee SD. Huo TI, et al. Gastroenterology. 2003 Jul;125(1):274-5; author reply 275. doi: 10.1016/s0016-5085(03)00816-3. Gastroenterology. 2003. PMID: 12870495 No abstract available.

7

Diabetes mellitus is a recurrence-independent risk factor in patients with hepatitis B virus-related hepatocellular carcinoma undergoing resection.

Huo TI, Wu JC, Lui WY, Lee PC, Huang YH, Chau GY, Tsay SH, Chang FY, Lee SD. Huo TI, et al. Eur J Gastroenterol Hepatol. 2003 Nov;15(11):1203-8. doi: 10.1097/00042737-200311000-00009. Eur J Gastroenterol Hepatol. 2003. PMID: 14560154

8

Diabetes mellitus is a risk factor for hepatic decompensation in patients with hepatocellular carcinoma undergoing resection: a longitudinal study.

Huo TI, Lui WY, Huang YH, Chau GY, Wu JC, Lee PC, Chang FY, Lee SD. Huo TI, et al. Am J Gastroenterol. 2003 Oct;98(10):2293-8. doi: 10.1111/j.1572-0241.2003.07688.x. Am J Gastroenterol. 2003. PMID: 14572582

9

Changing seroepidemiology of hepatitis B, C, and D virus infections in high-risk populations.

Huo TI, Wu JC, Wu SI, Chang AL, Lin SK, Pan CH, Huang YH, Chang FY, Lee SD. Huo TI, et al. J Med Virol. 2004 Jan;72(1):41-5. doi: 10.1002/jmv.10554. J Med Virol. 2004. PMID: 14635009

10

Selective prognostic impact of serum alpha-fetoprotein level in patients with hepatocellular carcinoma: analysis of 543 patients in a single center.

Huo TI, Huang YH, Lui WY, Wu JC, Lee PC, Chang FY, Lee SD. Huo TI, et al. Oncol Rep. 2004 Feb;11(2):543-50. Oncol Rep. 2004. PMID: 14719097

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

337 results

Search Page

Filters